In 2012, ECIO went from a biennial event to an annual fixture in the interventional radiological calendar. By making ECIO an annual event, CIRSE aims to support the advancement of interventional oncology as well as the interventional radiologists involved in it.
ECIO 2014
Start
Wed, 23 Apr 2014, 10:00
End
Sat, 26 Apr 2014, 19:00
WebSite
Venue:
ECIO 2014 - 5th European Conference on Interventional Oncology
Exhibit
Symposia
Workshops
Organiser
Sponsor
Congress date
23-26 April, 2014
Venue
ESTREL Convention Center
Sonnenallee 225
12057 Berlin
Germany
Organising Secretariat
CIRSE Central Office
Neutorgasse 9/6
1010 Vienna
Austria
Tel: 0043 1 904 2003
Fax: 0043 1 904 2003 30
Email: [email protected]
Full Scientific Programme of ECIO 2014
Wednesday, April 23| 08:30-10:00 | ||
| CF 101 | Clinical Focus Session | Lecture Room 1 |
| Early-stage HCC | ||
| Moderators: C. Ayuso (Barcelona/ES), B. Sangro (Pamplona/ES) | ||
|
101.1 101.2 101.3 101.4 101.5 |
When imaging is enough to diagnose HCC? V. Vilgrain (Clichy/FR) How to evaluate the patient before deciding therapy A. Forner (Barcelona/ES) Which early HCC wouldn't you resect? V. Mazzaferro (Milan/IT) Which early HCC wouldn't you ablate? L. Bianchi Cardona (Barcelona/ES) Bridging to transplantation: when and how S.J. Park (Daejeon/KR) | |
| 10:30-12:00 | ||
| JS 201 | Joint session | Lecture Room 1 |
| Novel advancements in locoregional therapies in HCC Joint session with ILCA (International Liver Cancer Association) | ||
| Moderators: P.R. Galle (Mainz/DE), R. Lencioni (Pisa/IT) | ||
|
201.1 201.2 201.3 201.4 |
Treatment of HCC: where do we stand and where are we heading? L. Bolondi (Bologna/IT) Overview of recent phase II-III trials assessing TACE in monotherapy or combination R. Lencioni (Pisa/IT) Critical appraisal of radioembolisation: can any ongoing trial change guidelines of management? B. Sangro (Pamplona/ES) Can systemic molecular therapies compete with TACE in intermediate HCC? P.R. Galle (Mainz/DE) | |
| 10:30-12:00 | ||
| CF 202 | Clinical Focus Session | Lecture Room 2 |
| How to follow up patients: clinical and imaging | ||
| Moderators: C. Dromain (Villejuif/FR), J. Lammer (Vienna/AT) | ||
|
202.1 202.2 202.3 202.4 202.5 |
Systemic therapy of HCC J.-F.H. Geschwind (Baltimore, MD/US) Bone ablation M.R. Callstrom (Rochester, MN/US) TACE for HCC M. Burrel (Barcelona/ES) Renal ablation D. Gervais (Boston, MA/US) Lung ablation D.E. Dupuy (Providence, RI/US) | |
| 10:30-12:00 | ||
| TA-HoW 1 | Hands-on Workshop | HoW Room 1 |
| Image-guided tumour ablation – bone | ||
| Please click here for further details. | ||
| 12:30-14:00 | ||
| Satellite Lunch Symposia | ||
| Please click here for further details. | ||
| 14:30-16:00 | ||
| CF 401 | Clinical Focus Session | Lecture Room 1 |
| Bone tumours | ||
| Moderators: G. Carrafiello (Varese/IT), B. Hamm (Berlin/DE) | ||
|
401.1 401.2 401.3 401.4 401.5 |
The role of radiation therapy L.M. Kenny (Brisbane, QLD/AU) The role of FUS W.M. Gedroyc (London/UK) The role of ablation in cure or palliation D.K. Filippiadis (Athens/GR) The role of percutaneous osteosynthesis and osteoplasty F. Deschamps (Villejuif/FR) The role of combined technique: needle plus catheter J. Garnon (Strasbourg/FR) | |
| 14:30-16:00 | ||
| TF 402 | Technical Focus Session | Lecture Room 2 |
| Ablation technologies: current status and future horizons | ||
| Moderators: N. Goldberg (Jerusalem/IL), J. Ricke (Magdeburg/DE) | ||
|
402.1 402.2 402.3 402.4 402.5 402.6 402.7 |
Radiofrequency ablation L. Crocetti (Pisa/IT) Electroporation C. Stroszczynski (Regensburg/DE) Microwaves T.K. Helmberger (Munich/DE) MR-guided HIFU I. Mindjuk (Dachau/DE) US-guided HIFU F. Orsi (Milan/IT) Cryoablation P.J. Littrup (Detroit, MI/US) Brachytherapy N. Tselis (Offenbach/DE) | |
| 14:30-16:00 | ||
| TA-HoW 2 | Hands-on Workshop | HoW Room 1 |
| Image-guided tumour ablation - lung | ||
| Please click here for further details. | ||
| 16:30-18:00 | ||
| CF 501 | Clinical Focus Session | Lecture Room 1 |
| Lung cancer | ||
| Moderators: N. Hosten (Greifswald/DE), S.C. Rose (San Diego, CA/US) | ||
|
501.1 501.2 501.3 501.4 501.5 |
Evaluation of lung function before and after surgery, SBRT and percutaneous ablation R. Orecchia (Milan/IT) SBRT, current results and ongoing trials R.E. Wurm (Frankfurt/DE) Ablation of primary lung cancer C.M. Sommer (Heidelberg/DE) Ablation of lung metastases S.B. Solomon (New York, NY/US) Vascular intervention for the palliation of lung cancer T. Sabharwal (London/UK) | |
| 16:30-18:00 | ||
| CF 502 | Clinical Focus Session | Lecture Room 2 |
| Neuroendocrine liver metastases | ||
| Moderators: T. de Baère (Villejuif/FR), R. Salem (Chicago, IL/US) | ||
|
502.1 502.2 502.3 502.4 502.5 |
Relative role of systemic therapy and intra-arterial therapy in NET M. Pavel (Berlin/DE) Embolotherapy for NET: technique and results B. Guiu (Montpellier/FR) Radioembolisation in NET: technique and results M.C. Soulen (Philadelphia, PA/US) Labelled peptides for therapy for NET – PPRT G. Paganelli (Milan/IT) How to evaluate response C. Dromain (Villejuif/FR) |
Thursday, April 24
| 08:30-10:00 | ||
| NH 801 | New Horizons | Lecture Room 2 |
| Ablation: adjuvant and neoadjuvant therapy | ||
| Moderators: P.L. Pereira (Heilbronn/DE), B.J. Wood (Bethesda, MD/US) | ||
|
801.1 801.2 801.3 801.4 |
What happens beyond ablation margins N. Goldberg (Jerusalem/IL) Chemotherapy N.E. Kemeny (New York, NY/US) Thermoablation and immunomodulation with cryoablation M. den Brok (Nijmegen/NL) Tumour-specific immune responses to radiofrequency S.A. Dromi (Bethesda, MD/US) | |
| 08:30-10:00 | ||
| VL 802 | Video Learning | Lecture Room 1 |
| How I do it: transcatheter therapy | ||
| Moderators: A.-M. Belli (London/UK), R.A. Morgan (London/UK) | ||
|
802.1 802.2 802.3 802.4 802.5 |
Portal vein embolisation D.C. Madoff (New York, NY/US) Lipiodol TACE T. de Baère (Villejuif/FR) DEB-TACE J.G. Caridi (New Orleans, LA/US) Radioembolisation P. Reimer (Karlsruhe/DE) Hepatic arterial ports F. Orsi (Milan/IT) | |
| 10:30-11:30 | ||
| HL 901 | Honorary Lecture | Lecture Room 1 |
| Moderators: A. Adam (London/UK), T.K. Helmberger (Munich/DE) | ||
| Laudation: J. Lammer (Vienna/AT) | ||
|
901.1 |
20 years of Interventional Oncology, and future trends for 2020 | |
| R. Lencioni (Pisa/IT) | ||
| 10:30-12:00 | ||
| TA-HoW 3 | Hands-on Workshop | HoW Room 1 |
| Image-guided tumour ablation - liver | ||
| Please click here for further details. | ||
| 12:30-14:00 | ||
| Satellite Lunch Symposia | ||
| Please click here for further details. | ||
| 14:30-16:00 | ||
| JS 1101 | Joint session | Lecture Room 1 |
| Interventional oncology and radiation oncology: combination or competition? Joint session with ESTRO (European SocieTy for Radiotherapy and Oncology) | ||
| Moderators: L.M. Kenny (Brisbane, QLD/AU), P. Poortmans (Tilburg/NL) | ||
|
1101.1 1101.2 1101.3 1101.4 1101.5 |
External radiation therapy: from linear accelerator, through IMRT, to SBRT P. Poortmans (Tilburg/NL) Combining external radiation therapy and percutaneous ablation R. Orecchia (Milan/IT) What is brachytherapy? P. Hoskin (Northwood/UK) Percutaneous liver brachytherapy J. Ricke (Magdeburg/DE) Percutaneous lung brachytherapy F. Collettini (Berlin/DE) | |
| 14:30-16:00 | ||
| RE-HoW 1 | Hands-on Workshop | HoW Room 2 |
| Radioembolisation - how to start a practice? | ||
| Please click here for further details. | ||
| 14:30-16:00 | ||
| TA-HoW 4 | Hands-on Workshop | HoW Room 1 |
| Image-guided tumour ablation - kidney | ||
| Please click here for further details. | ||
| 16:30-18:00 | ||
| JS 1201 | Joint Session | Lecture Room 2 |
| All you need to know for running a clinical trial Joint session with EORTC (European Organisation for Research and Treatment of Cancer) | ||
| Moderators: P. Bourguet (Rennes/FR), M.J. Lee (Dublin/IE) | ||
1201.1 |
Introduction: the challenges of cancer clinical research in 2014 P. Bourguet (Rennes/FR) Challenges for biomarker development Y. Liu (Brussels/BE) Methodology for conducting clinical trials in oncology M. Mauer (Brussels/BE) Endpoints in interventional oncology Y. Arai (Tokyo/JP) | |
| 16:30-18:00 | ||
| TF 1202 | Technical Focus Session | Lecture Room 1 |
| Image guidance in IO | ||
| Moderators: E. Brountzos (Athens/GR), B.J. Wood (Bethesda, MD/US) | ||
|
1202.1 1202.2 1202.3 1202.4 1202.5 1202.6 |
Conebeam CT is the ideal interventional oncology suite J.Y. Choo (Ansan/KR) MDCT +/- C-arm is the ideal interventional suite C.T. Sofocleous (New York, NY/US) Future of MR imaging in monitoring and guiding IO P.L. Pereira (Heilbronn/DE) US fusion-imaging: potential and limitations C. Ewertsen (Copenhagen/DK) Intra-procedural treatment planning for ablation V. Válek (Brno/CZ) Economic issues P. Reimer (Karlsruhe/DE) |
Friday, April 25
| 08:30-10:00 | ||
| CF 1501 | Clinical Focus Session | Lecture Room 1 |
| Colorectal liver metastases | ||
| Moderators: D. Arnold (Freiburg/DE), T.K. Helmberger (Munich/DE) | ||
|
1501.1 1501.2 1501.3 1501.4 1501.5 1501.6 |
From systemic to intra-arterial chemotherapy N.E. Kemeny (New York, NY/US) TACE in colorectal metastases G. Narayanan (Miami, FL/US) Ablation and resection as curative treatments: competition or synergy? R. Biffi (Milan/IT) Which patient, when to ablate T. Albrecht (Berlin/DE) Radioembolisation and drug-eluting beads in the palliative setting W.S. Rilling (Milwaukee, WI/US) The role of IR in combination strategies A. Denys (Lausanne/CH) | |
| 08:30-10:00 | ||
| IS 1502 | Interactive Session | Lecture Room 2 |
| Management of complications I | ||
| Moderators: C. Ayuso (Barcelona/ES), P.R. Mueller (Boston, MA/US) | ||
|
1502.1 1502.2 1502.3 1502.4 1502.5 |
Lung ablation R.D. Suh (Los Angeles, CA/US) Liver ablation L. Crocetti (Pisa/IT) Bone ablation D.K. Filippiadis (Athens/GR) Liver chemoembolisation K. Malagari (Athens/GR) Liver radioembolisation J.I. Bilbao (Pamplona/ES) | |
| 10:30-12:00 | ||
| CF 1601 | Clinical Focus Session | Lecture Room 2 |
| Outcome measures and quality assurance in interventional oncology | ||
| Moderators: A. Adam (London/UK), P.L. Pereira (Heilbronn/DE) | ||
|
1601.1 1601.2 1601.3 1601.4 |
The role of EORTC in the development of oncological services Y. Liu (Brussels/BE) Outcome measures and quality assurance: why they matter L.M. Kenny (Brisbane, QLD/AU) Research in interventional oncology: what we know, and what we need to know R. Lencioni (Pisa/IT) Panel discussion: ‘Interventional oncology – what it would take to move from technology to clinical practice’ | |
| 10:30-12:00 | ||
| VL 1602 | Video Learning | Lecture Room 1 |
| How I do it: percutaneous techniques | ||
| Moderators: R. Bale (Innsbruck/AT), C.T. Sofocleous (New York, NY/US) | ||
|
1602.1 1602.2 1602.3 1602.4 1602.5 |
Lung cryotherapy T. de Baère (Villejuif/FR) Kidney cryotherapy D.J. Breen (Southampton/UK) Liver microwave ablation C.T. Sofocleous (New York, NY/US) Bone cementoplasty and osteosynthesis F. Deschamps (Villejuif/FR) Bone cryoablation A. Gangi (Strasbourg/FR) | |
| 12:30-14:00 | ||
| Satellite Lunch Symposia | ||
| Please click here for further details. | ||
| 14:30-16:00 | ||
| JS 1801 | Joint session | Lecture Room 2 |
| How do I do it - top 5 clinical pearls Joint session with WCIO (World Conference on Interventional Oncology) | ||
| Moderators: R. Lencioni (Pisa/IT), M.C. Soulen (Philadelphia, PA/US) | ||
|
1801.1 1801.2 1801.3 1801.4 1801.5 |
Lung ablation C.T. Sofocleous (New York, NY/US) TACE Y. Arai (Tokyo/JP) DEB-TACE J.-F.H. Geschwind (Baltimore, MD/US) Radioembolisation R. Salem (Chicago, IL/US) Clinical management of the oncology patient: general principles M.C. Soulen (Philadelphia, PA/US) | |
| 14:30-16:00 | ||
| IS 1802 | Interactive Session | Lecture Room 1 |
| Multidisciplinary Tumour Board: Primary liver tumours (HCC, cholangiocarcinoma) | ||
| Co-ordinator: F. Orsi (Milan/IT) | ||
| Panellists: D. Arnold (Freiburg/DE), A. Denys (Lausanne/CH), T.K. Helmberger (Munich/DE), S.J. Park (Daejeon/KR), G. Torzilli (Milan/IT) | ||
| 14:30-16:00 | ||
| RE-HoW 2 | Hands-on Workshop | HoW Room 2 |
| Radioembolisation - case-based discussions | ||
| Please click here for further details. | ||
| 16:30-18:00 | ||
| CF 1901 | Clinical Focus Session | Lecture Room 1 |
| Kidney cancer | ||
| Moderators: P.R. Mueller (Boston, MA/US), S.L. Samuels (Miami, FL/US) | ||
|
1901.1 1901.2 1901.3 1901.4 1901.5 1901.6 |
Changing our indications for ablation in the kidney D. Gervais (Boston, MA/US) How to manage ablation in patients with multiple recurrences of RCC J.-M. Correas (Paris/FR) Which ablation techniques? M.R. Callstrom (Rochester, MN/US) Prevention and management of complications in kidney ablation D.J. Breen (Southampton/UK) Patient follow-up after kidney ablation N. Grenier (Bordeaux/FR) When should we combine therapies in kidney cancer? B. Gebauer (Berlin/DE) | |
| 16:30-18:00 | ||
| CF 1902 | Clinical Focus Session | Lecture Room 2 |
| Palliative cancer management | ||
| Moderators: X. Buy (Bordeaux/FR), J.H. Peregrin (Prague/CZ) | ||
|
1902.1 1902.2 1902.3 1902.4 1902.5 |
Systemic pain therapy: instruction for use C.I. Ripamonti (Milan/IT) Percutaneous nerve blocking J. Garnon (Strasbourg/FR) Palliative embolisation: bleeding tumours P. Chabrot (Clermont-Ferrand/FR) Palliative embolisation: pain F. Orsi (Milan/IT) Denver shunt L.G. Martin (Atlanta, GA/US) |
Saturday, April 26
| 08:30-10:00 | ||
| IS 2101 | Interactive Session | Lecture Room 1 |
| Management of complications II | ||
| Moderators: A. Denys (Lausanne/CH), P.R. Mueller (Boston, MA/US) | ||
|
2101.1 2101.2 2101.3 2101.4 2101.5 |
Lung ablation A. Gillams (London/UK) Liver ablation S.L. Samuels (Miami, FL/US) Bone ablation P.J. Littrup (Detroit, MI/US) Liver chemoembolisation H.S. Kim (Pittsburgh, PA/US) Liver radioembolisation R.J. Lewandowski (Chicago, IL/US) | |
| 10:30-12:00 | ||
| IS 2201 | Interactive Session | Lecture Room 1 |
| Multidisciplinary Tumour Board: Bone tumours | ||
| Co-ordinator: A. Gangi (Strasbourg/FR) | ||
| Panellists: M.R. Callstrom (Rochester, MN/US), A. Italiano (Bordeaux/FR), L.M. Kenny (Brisbane, QLD/AU), G. Missenard (Villejuif/FR), C.I. Ripamonti (Milan/IT) |
Wednesday | Thursday | Friday
Wednesday, April 23, 2014TOP| 12:30-13:15 | ||
| SY 301 | BTG | Lecture Room 1 |
| An update on the radioembolisation of liver cancer with TheraSphere® | ||
| Moderator: T.K. Helmberger (Munich/DE) | ||
|
301.1 301.2 |
A review of the clinical experience with TheraSphere® in secondary liver cancer from Marburg Hospital A.H. Mahnken (Marburg/DE) A review of the clinical experience with TheraSphere® in HCC from Leipzig Hospital M. Moche (Leipzig/DE) | |
| 13:15-13:45 | ||
| SY 302 | Merit Medical | Lecture Room 1 |
| Irinotecan eluting microparticles for chemoablation of colorectal cancer liver metastases | ||
| Moderator: G.A. Maleux (Leuven/BE) | ||
| 302.1 | P.E. Huppert (Darmstadt/DE) | |
| Thursday, April 24, 2014TOP | ||
| 12:30-13:15 | ||
| SY 1001 | Terumo Europe | Lecture Room 1 |
| TERUMO solution for interventional oncology | ||
| Moderator: P.L. Pereira (Heilbronn/DE) | ||
|
1001.1 1001.2 1001.3 |
Review of drug-eluting beads literature in hepatocellular carcinoma M. Burrel (Barcelona/ES) DEBIRI in the treatment algorithm of CRC liver metastases H. Prenen (Leuven/BE) The experience of Aarhus University Hospital with MicroThermX microwave ablation system in liver tumours D. Tonner (Aarhus/DK) | |
| 13:15-14:00 | ||
| SY 1002 | Sirtex Medical | Lecture Room 1 |
| SIR-Spheres® microspheres – optimising tumour coverage | ||
| Moderator: J.I. Bilbao (Pamplona/ES) | ||
|
1002.1 1002.2 |
SIR-Spheres® microspheres – distribution is key M. Pech (Magdeburg/DE) Controlled and flexible administration with SIR-Spheres® microspheres P. Boardman (Oxford/UK) | |
| Friday, April 25, 2014TOP | ||
| 12:30-13:15 | ||
| SY 1701 | Siemens AG Healthcare Sector | Lecture Room 1 |
| 3D image guidance in CT and interventional angiography | ||
| Moderator: A. Gangi (Strasbourg/FR) | ||
|
1701.1 1701.2 |
Challenging interventions in the angio suite – PAE and RF lung ablation O. Pellerin (Paris/FR) CT-guided intervention – how 3D helps over 2D A. Gangi (Strasbourg/FR) | |
| 13:15-13:45 | ||
| SY 1702 | Surefire Medical | Lecture Room 1 |
| New randomised data on a flow directional catheter: from eliminating reflux to improving penetration | ||
| Moderator: T.F. Jakobs (Munich/DE) | ||
| 1702.1 | A. Arepally (Atlanta, GA/US) | |
| Registration Fees (Euro) | Early - | Middle - | Late - after February 20th 2014 |
|
CIRSE Member | € 390 | € 550 | € 750 |
|
Non-Member | € 590 | € 790 | € 860 |
|
Resident/Nurse/ Radiographer* | € 250 | € 385 | € 420 |
| Undergraduate Student** | € 0 | € 0 | € 0 |
| Early Registration Fees available until 23.01.2014, 23:59 CET | |||
| Middle Registration Fees available until 20.02.2014, 23:59 CET | |||
| Umsatzsteuerbefreiung nach § 4 Nr. 22 a UStG Registration fee deemed as VAT exempt based on article 4 of the German VAT Law Nr. 22a UStG. | |||
* registration needs to be accompanied by a confirmation, signed by the head of department **For undergraduate medical students. Registration needs to be accompanied by a confirmation | |||
Reduced CIRSE Member Registration:
is only available for members of CIRSE (Cardiovascular and Interventional Radiological Society of Europe) in good standing.
Method of Payment:
Registration fees are to be paid in Euros (€) by:
- Bank Transfer
- Credit Card (Visa or Mastercard)
Our accepted onsite payment methods are Credit Card (Visa or Mastercard) and Cash (payment can be settled in Euros only)
Cancellation of Congress Registration:
CIRSE GmbH will not refund any registration fees in case of
cancellation of the registration or change of registration category by
the participant.
CIRSE GmbH however offers all pre-registered participants the
possibility to take out cancellation insurance with its partner
"Europäische Reiseversicherung". The insurance can only be booked during
and until finalisation of the online registration process. The refund
of the participant's registration fee due to cancellation of the
registration or the change of registration category is only possible
with a valid insurance. CIRSE GmbH itself will not refund any
registration fees. All requests must be made to "Europäische
Reiseversicherung" directly. Refunds will be given according to the
terms and conditions of the "Europäische Reiseversicherung". CIRSE GmbH
shall not be responsible for any refunds of registration fees.
Name Changes:
Will be handled as a cancellation and new registration.
Onsite registration desk opening hours:
| Tuesday: April 22 | 16:00 - 18:00 |
| Wednesday: April 23 | 07:30 - 18:00 |
| Thursday: April 24 | 07:30 - 18:00 |
| Friday: April 25 | 07:30 - 18:00 |
| Saturday: April 26 | 08:00 - 11:00 |
Additional Information:
All ECIO 2014 registrants will be able to print out an invoice of the registration using their personal log-in details at www.ecio.org and at www.cirse.org.
Invoices will be issued by the CIRSE Congress Research Education GmbH, Neutorgasse 9, 1010 Vienna, Austria.
Advisory BoardTOP
Local Host CommitteeTOP
Bernd Hamm (Berlin), Chairman
Christian E. Althoff (Berlin)
Bernhard Gebauer (Berlin)
Peter E. Huppert (Darmstadt)
Philippe L. Pereira (Heilbronn)
Jens Ricke (Magdeburg)
Christian Scheurig-Münkler (Berlin)
Christian Stroszczynski (Regensburg)
 |  |  |
|
Andreas Adam (London/UK) |
Thierry de Baère (Villejuif/FR) |
Johannes Lammer (Vienna/AT) |
 |  |  |
|
Riccardo Lencioni (Pisa/IT) |
Jan H. Peregrin (Prague/CZ) |
Jim A. Reekers (Amsterdam/NL) |
Scientific Programme CommitteeTOP
|  |  |  |
|
Thierry de Baère (Villejuif/FR), Chairman |
Thomas Helmberger (Munich/DE), Deputy Chairman |
Carmen Ayuso (Barcelona/ES) |
Anna-Maria Belli (London/UK) |
 |  |  |  |
|
Alban Denys (Lausanne/CH) |
Afshin Gangi (Strasbourg/FR) |
Jean-François H. Geschwind (Baltimore, MD/US) |
Patrick Haage (Wuppertal/DE) |
 |  |  |  |
|
Bernd Hamm (Berlin/DE) |
Robert A. Morgan (London/UK) |
Franco Orsi (Milan/IT) |
Philippe L. Pereira (Heilbronn/DE) |
Bernd Hamm (Berlin), Chairman
Christian E. Althoff (Berlin)
Bernhard Gebauer (Berlin)
Peter E. Huppert (Darmstadt)
Philippe L. Pereira (Heilbronn)
Jens Ricke (Magdeburg)
Christian Scheurig-Münkler (Berlin)
Christian Stroszczynski (Regensburg)
More events
Thu, 25 Apr 2024 - Sat, 27 Apr 2024
Fri, 26 Apr 2024 - Sun, 28 Apr 2024
Sun, 28 Apr 2024 - Wed, 1 May 2024
Fri, 3 May 2024 - Tue, 7 May 2024
Fri, 3 May 2024 - Sun, 5 May 2024
Sun, 5 May 2024 - Mon, 6 May 2024
Thu, 9 May 2024 - Sat, 11 May 2024
Thu, 9 May 2024 - Fri, 10 May 2024
Mon, 13 May 2024 - Fri, 17 May 2024
Royal College of Physicians of Edinburgh
Queen Street
9
Scotlandfalse, Scotland EH2 1JQ
United Kingdom
Scotlandfalse, Scotland EH2 1JQ
United Kingdom
